The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 3, 2011, Pages 791-795

  Dinu, Ilie Robert ^a   Popa, Simona Georgiana ^a   MoţA, Maria ^a   MotA E ^a   Stǎnciulescu, Camelia ^a   Ioana, M ^a   Cruce, M ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Adiponectin; CB1 receptor; CNR1 polymorphism; Endocannabinoid system

Indexed keywords

ADIPONECTIN; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADULT; AGED; CASE-CONTROL STUDIES; ENDOCANNABINOIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB1;

EID: 80052674524     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R, The emerging role of the endocannabinoid system in endocrine regulation and energy balance, Endocr Rev, 2006, 27(1):73-100.
2. Lutz B, Molecular biology of cannabinoid receptors, Prostaglandins Leukot Essent Fatty Acids, 2002, 66(2-3):123-142.
3. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC, Cannabinoid receptor localization in brain, Proc Natl Acad Sci U S A, 1990, 87(5):1932-1936.
4. Cota D, Woods SC, The role of the endocannabinoid system in the regulation of energy homeostasis, Curr Opin Endocrinol Diab, 2005, 12(5):338-351.
5. Demuth DG, Molleman A, Cannabinoid signaling, Life Sci, 2006, 78(6):549-563.
6. Roche R, Hoareau L, Bes-Houtmann S, Gonthier MP, Laborde C, Baron JF, Haffaf Y, Cesari M, Festy F, Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes, Histochem Cell Biol, 2006, 126(2):177-187.
7. Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Mo FM, Liu J, Kunos G, Evidence for novel cannabinoid receptors, Pharmacol Ther, 2005, 106(2):133-145.
8. van der Stelt M, Trevisani M, Vellani V, De Petrocellis L, Schiano Moriello A, Campi B, McNaughton P, Geppetti P, Di Marzo V, Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels, EMBO J, 2005, 24(17):3026-3037.
9. Maingret F, Patel AJ, Lazdunski M, Honoré E, The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1, EMBO J, 2001, 20(1-2):47-54.
10. Mo FM, Offertáler L, Kunos G, Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1, Eur J Pharmacol, 2004, 489(1-2):21-27.
11. Piomelli D, The molecular logic of endocannabinoid signaling, Nat Rev Neurosci, 2003, 4(11):873-884.
12. McFarland MJ, Barker EL, Anandamide transport, Pharmacol Ther, 2004, 104(2):117-135.
13. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P, CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity, Int J Obes Relat Metab Disord, 2004, 28(4):640-648.
14. Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thöne-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, Lutz B, Stalla GK, Pagotto U, The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis, J Clin Invest, 2003, 112(3):423-431.
15. Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, Péleraux A, Pénarier G, Soubrié P, Le Fur G, Galiègue S, Casellas P, The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance, FASEB J, 2005, 19(11):1567-1569.
16. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara S, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y, Genomic structure and mutations in adiposespecific gene, adiponectin, Int J Obes Relat Metab Disord, 2000, 24(7):861-868.
17. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A, Reninangiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans, J Hypertens, 2008, 26(5):831-843.
18. Côté M, Mauriège P, Bergeron J, Alméras N, Tremblay A, Lemieux I, Després JP, Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men, J Clin Endocrinol Metab, 2005, 90(3):1434-1439.
19. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrié P, The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells, Mol Pharmacol, 2003, 63(4):908-914.
20. Dinu IR, Popa S, Bîcu M, Mota E, Mota M, The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects, Rom J Intern Med, 2009, 47(1):9-18.
21. Sasieni PD, From genotypes to genes: doubling the sample size, Biometrics, 1997, 53(4):1253-1261.
22. Nesto RW, Mackie K, Endocannabinoid system and its implications for obesity and cardiometabolic risk, Eur Heart J Suppl, 2008, 10(Suppl B):B34-B41.
23. Watanabe T, Kubota N, Ohsugi M, Kubota T, Takamoto I, Iwabu M, Awazawa M, Katsuyama H, Hasegawa C, Tokuyama K, Moroi M, Sugi K, Yamauchi T, Noda T, Nagai R, Terauchi Y, Tobe K, Ueki K, Kadowaki T, Rimonabant ameliorates insulin resistance via both adiponectin- dependent and adiponectin-independent pathways, J Biol Chem, 2009, 284(3):1803-1812.
24. Storr M, Emmerdinger D, Diegelmann J, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Brand S, The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease, PLoS One, 2010, 5(2):e9453.
25. de Luis DA, González Sagrado M, Aller R, Izaola O, Conde R, Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity, Metabolism, 2011, 60(2):272-276.
26. Gazzerro P, Caruso MG, Notarnicola M, Misciagna G, Guerra V, Laezza C, Bifulco M, Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population, Int J Obes (Lond), 2007, 31(6):908-912.
27. de Luis DA, González Sagrado M, Aller R, Izaola O, Conde R, Romero E, G1359A polymorphism of the cannabinoid receptor gene (CNR1) and insulin resistance in patients with diabetes mellitus type 2, Nutr Hosp, 2010, 25(1):34-38.
28. Peeters A, Beckers S, Mertens I, Van Hul W, Van Gaal L, The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men, Endocrine, 2007, 31(2):138-141.
29. Lieb W, Manning AK, Florez JC, Dupuis J, Cupples LA, McAteer JB, Vasan RS, Hoffmann U, O'Donnell CJ, Meigs JB, Fox CS, Variants in the CNR1 and the FAAH genes and adiposity traits in the community, Obesity (Silver Spring), 2009, 17(4):755-760.
30. Müller TD, Reichwald K, Wermter AK, Brönner G, Nguyen TT, Friedel S, Koberwitz K, Engeli S, Lichtner P, Meitinger T, Schäfer H, Hebebrand J, Hinney A, No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents, Mol Genet Metab, 2007, 90(4):429-434.